Bioventus Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
BVS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4721 Emperor Boulevard, Suite 100, Durham, NC

Insiders trading volume in the past year

Bioventus Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Martin P. Sutter Director $62.3M Jun 11, 2024
John A. Bartholdson Director, 10%+ Owner $59.8M +$902K +1.53% Aug 16, 2024
Juniper Investment Company, LLC 10%+ Owner $28.3M Aug 10, 2023
Stavros G. Vizirgianakis Director $11.6M Jun 16, 2022
Robert E. Claypoole President and CEO, Director $1.55M Jan 11, 2024
William A. Hawkins Director $1.22M Jun 11, 2024
Anthony P. Bihl III Interim CEO, Director $682K Aug 18, 2023
Mark Leonard Singleton Svp & Cfo $654K -$181K -21.6% Jun 21, 2024
Anthony D'Adamio SVP & General Counsel $648K -$130K -16.8% Jun 21, 2024
Guy P. Nohra Director $601K Jun 11, 2024
Susan M. Stalnecker Director $503K Jun 11, 2024
Guido J. Neels Director $405K Jun 11, 2024
John Nosenzo Fmr. Chief Commercial Officer $361K Apr 1, 2022
Katrina J. Church SVP & Chief Compliance Officer $280K -$78.3K -21.9% Jun 21, 2024
Mary Kay Ladone Director $249K Jun 16, 2024
Pat Beyer Director $237K Jun 16, 2024
Michelle McMurry-Heath Director $229K Jun 16, 2024
Gregory O. Anglum Svp & Cfo $228K Feb 11, 2022
Philip G. Cowdy Director $48.4K Apr 1, 2022
Kenneth Michael Reali Fmr. CEO and Director, Director Mar 14, 2022
Alessandra Pavesio SVP & Chief Science Officer Apr 1, 2022

Recent Insider Transactions by Companies or Individuals for Bioventus Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.